SCHEMBL7796993

SCHEMBL7796993

O=C(CCCNC(=O)O)Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.49
TSHR P16473 1/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45
SIGMAR1 Q99720 2/20 0.45
PTPN1 P18031 1/20 0.44
ACKR3 P25106 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2828273 0.81 ALDH1A1 (0.67) ALDH1A1HPGDSMN1; SMN2TSHRNPC1
SCHEMBL2828269 0.81 ALDH1A1 (0.67) ALDH1A1HPGDSMN1; SMN2TSHRNPC1
SCHEMBL9644637 0.80 ALDH1A1 (0.50) ALDH1A1HPGDSMN1; SMN2TSHRNPC1
SCHEMBL28813918 0.80 ALDH1A1 (0.59) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL28977512 0.79 ALDH1A1 (0.64) ALDH1A1HPGDSMN1; SMN2TSHRNPC1
SCHEMBL3718010 0.79 ATM (0.60) ALDH1A1HPGDTSHRNPC1RAB9A
SCHEMBL7790183 0.79 EGFR (0.46) NPC1RAB9ALMNASIGMAR1
SCHEMBL2998029 0.78 TSHR (0.65) ALDH1A1HPGDSMN1; SMN2TSHRNPC1
SCHEMBL4582840 0.78 PTPN1 (0.63) ALDH1A1HPGDSMN1; SMN2TSHRMEN1
SCHEMBL296300 0.76 TSHR (0.61) ALDH1A1HPGDSMN1; SMN2TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159260-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000055124-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed